Asperger's Disorder Clinical Trial
— ASSTOfficial title:
The Multi-media Social Skills Project: Validation of an Intervention for Adolescents With Autism Spectrum Disorders
NCT number | NCT01031823 |
Other study ID # | 32300 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2009 |
Est. completion date | July 10, 2013 |
Verified date | June 2019 |
Source | Milton S. Hershey Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a pre-test, post-test single group design with follow-up at month three. Twenty-four individuals total will participate in this study with 6 participants in each of 4 cohorts. Participants and their parents will complete pre-test measures including both paper and pencil measures and a video-recording to assess the participant's social interaction skills and fluency. These adolescents will participate in both group therapy and peer generalization sessions once a week over the course of twelve weeks. Upon completion of the intervention, participants and parents will complete paper and pencil and video post-test measures. Participants will be encouraged to participate in one follow-up session where the paper and pencil and video measures will be completed again.
Status | Completed |
Enrollment | 50 |
Est. completion date | July 10, 2013 |
Est. primary completion date | October 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 13 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Between 13 and 17 years of age - A primary diagnosis of Asperger's Syndrome or high-functioning autism, as confirmed by the Autism Disorders Interview-Revised (ADIR; Rutter & LeCourteur, 1995) - An IQ of 70 or above on the Kaufman Brief Intelligence Test, Second Edition (KBIT-2; Kaufman & Kaufman, 1990) - Local to Central Pennsylvania region Exclusion Criteria: - A significant language delay - Difficulty with aggression directed at peers - A primary thought disorder - A secondary disorder of anxiety or depression so severe as to prevent the individual's participation in the treatment |
Country | Name | City | State |
---|---|---|---|
United States | Penn State College of Medicine, Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Milton S. Hershey Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Social Fluency | 12 week, 3 month | ||
Secondary | Loneliness Scale (Asher & Wheeler, 1985) | 12 week, 3 month | ||
Secondary | Social Responsiveness Scale (SRS; Constantino, 2002) | 12 week, 3 month | ||
Secondary | Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) | 12 week, 3 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
Withdrawn |
NCT00376194 -
Mercury Chelation to Treat Autism
|
Phase 2 | |
Terminated |
NCT01592773 -
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
|
Phase 2 | |
Enrolling by invitation |
NCT01078844 -
Memantine in Adult Autism Spectrum Disorder
|
N/A | |
Completed |
NCT00844753 -
Atomoxetine, Placebo and Parent Management Training in Autism
|
Phase 4 | |
Completed |
NCT00352196 -
Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
|
Phase 4 | |
Completed |
NCT01631851 -
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
|
N/A | |
Completed |
NCT01086475 -
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
|
Phase 3 | |
Active, not recruiting |
NCT02199925 -
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
|
Phase 4 | |
Completed |
NCT01592786 -
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
|
Phase 2 | |
Completed |
NCT01808066 -
GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs
|
N/A | |
Completed |
NCT00198055 -
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
|
Phase 2 | |
Active, not recruiting |
NCT01031407 -
Cognitive Neuroscience of Autism Spectrum Disorders
|
||
Completed |
NCT00308074 -
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
|
Phase 2 | |
Completed |
NCT00808782 -
The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder
|
N/A |